The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
140 jobs Number of planned job creations
Announcement Date
8 July 2020
Employment effect (start)
8 July 2020
Foreseen end date
1 March 2022
Description
Gilead Sciences is to invest approximately €7 million in the company’s Irish operations, opening a new base in Dublin and creating 140 jobs. As part of this expansion, the company will also establish a paediatric centre of excellence in Ireland.
The company said it expects to fill 80 of the positions over the coming 12 months, with the remainder hired by early 2022. The new jobs will include clinical development, process development and analytical operations, legal, human resources, supply chain, information technology, facilities and engineering, and financial shared services positions.
Eurofound (2020), Gilead Sciences, Business expansion in Ireland, factsheet number 102179, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/102179.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
